Yatharth Hospital & Trauma Care Services Limited has announced the closure of its trading window for dealing in company securities, effective October 1, 2026. This measure is taken in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct.

The restriction applies to all designated persons and their immediate relatives. The trading window will remain closed until 48 hours after the declaration of the unaudited financial results for the second quarter and half year ending September 30, 2026. The company stated that all designated persons have already been informed of this development.

Regulatory Compliance and Timeline

The closure is a standard procedural requirement to prevent insider trading during the sensitive period preceding the announcement of financial performance. The specific dates and regulatory framework are outlined below:

The date of the Board Meeting scheduled to approve these financial results will be intimated in due course. Investors and market participants should note that the reopening of the trading window is strictly tied to the public disclosure of the quarterly earnings.

Corporate Governance Context

This action reflects the company's adherence to corporate governance norms mandated by Indian securities regulators. By restricting trading activity among insiders, the company aims to ensure a level playing field for all investors during the pre-announcement phase. The disclosure regarding the trading window closure is available on the company's investor relations webpage for public record.

Yatharth Hospital & Trauma Care Services Limited held its 19th Annual General Meeting (AGM) on Friday, September 25, 2026, via video conferencing. The meeting was presided over by Mr. Yatharth Tyagi, Whole-time Director, in the absence of Chairman Dr. Ajay Kumar Tyagi.

Shareholders approved several key resolutions, including the adoption of audited financial statements for FY26 and the re-appointment of Dr. Ajay Kumar Tyagi as a director retiring by rotation. Significant approvals included the ratification of the cost auditor's remuneration for FY27 and consent for a material related party transaction.

Key shareholder approvals

The AGM focused on governance updates and employee incentive structures. Two special resolutions were passed to support long-term growth and talent retention:

• Modification of IPO proceeds: Approval was granted for the modification or revision of the objects and terms of utilisation of Initial Public Offering (IPO) proceeds.
• New ESOP Scheme: The Yatharth Hospital & Trauma Care Services Employee Stock Option Scheme - 2026 was approved. This includes the grant of options to employees of subsidiary companies in India under this scheme.

Meeting proceedings and attendance

The quorum requirement was met with members participating through remote e-voting and live e-voting during the session. The Company Secretary confirmed that there were no qualifications in the Statutory Auditor's Report or Secretarial Auditor's Report for the period.

Key management personnel present included Mr. Amit Kumar Singh (Group CEO), Mr. Pankaj Prabhakar (Group CFO), and Mr. Nitin Gupta (Group COO). Independent Directors Mrs. Promila Bhardwaj, Dr. Mukesh Sharma, Dr. Sanjeev Upadhyaya, and Mr. Ramesh Krishnan attended virtually.

What the Numbers Show

While all resolutions were passed with the requisite majority, voting patterns revealed significant divergence between promoter and institutional investor sentiment on specific items. For the approval of the Employee Stock Option Scheme - 2026, public institutions voted 83.85% against the resolution, casting 12,086,281 votes against compared to 2,327,936 in favour. In contrast, promoters voted unanimously in favour. Similarly, for the material related party transaction, public institutions cast 39.43% of their votes against the proposal, indicating substantial institutional skepticism regarding related-party dealings despite their eventual approval.